×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | 3.25 | -4.52 | NA | -18.44 | 0 | |
| OXYGENTA PHARMACEUTICAL LIMITE | 495.16 | -21.53 | 494.67 | -0.60 | 456.0 | |
| Fredun Pharmaceuticals Limited | 1,674.07 | 70.72 | 1,654.38 | 14.98 | 453 | 21.8 |
| BROOKS LABORATORIES LTD. | 239.37 | 13.72 | 233.17 | 0.51 | 445 | 146.0 |
OXYGENTA PHARMACEUTICAL LIMITED, with Security Code 524636, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 7.9 | 8.2 | 6.9 | 13.1 | 9.2 | 10.6 | 12.6 | 14.0 | 33.2 | 49.5 |
| Expenses | 10.2 | 10.4 | 10.5 | 15.1 | 11.6 | 12.2 | 14.4 | 16.2 | 37.6 | 50.6 |
| Operating Profit | -2.3 | -2.2 | -3.6 | -2.0 | -2.5 | -1.6 | -1.8 | -2.2 | -4.4 | -1.2 |
| OPM % | -29.62% | -27.44% | -52.97% | -15.11% | -26.99% | -15.31% | -14.13% | -15.51% | -13.12% | -2.37% |
| Other Income | -0.3 | -0.1 | -0.1 | 0.0 | 0.0 | 0.3 | 0.0 | 0.7 | 0.5 | -0.2 |
| Interest | 0.2 | 0.9 | 0.3 | 0.3 | 0.4 | 0.6 | 0.4 | 0.7 | 0.4 | 2.1 |
| Depreciation | 0.4 | 0.9 | 0.5 | 0.8 | 0.7 | 0.6 | 0.6 | 0.7 | 0.7 | 0.2 |
| Profit before tax | -2.9 | -4.0 | -4.4 | -3.2 | -3.5 | -2.8 | -2.8 | -2.8 | -5.0 | -3.5 |
| Tax % | 0% | 4.8% | 0% | -0.6% | 6.5% | -409.9% | -51.6% | 2.9% | -20.8% | 0% |
| Net Profit | -3.3 | -4.3 | -4.6 | -3.2 | -3.8 | 8.0 | -1.4 | -2.9 | -3.9 | -2.2 |
| EPS in Rs | -2.29 | -3.02 | -1.65 | -0.76 | -1.07 | 2.44 | -0.37 | -0.78 | -1.12 | 0 |
No Consolidated data available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 32% |
| 5 Years: | 14% |
| 3 Years: | -9% |
| TTM: | 89% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | -2% |
| 3 Years: | 0% |
| TTM: | 98% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 27% |
| 5 Years: | 0% |
| 3 Years: | 59% |
| 1 Year: | 155% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|